Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

NCT07151378 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

PARKINSON DISEASE (Disorder)

Interventions

DRUG: LECIG (levodopa, carbidopa, entacapone intestinal gel)
DRUG: Best oral medication

Sponsor

University Hospital Tuebingen